在老年人中,在全关节整形术后,与跌倒相关的术前因素
Craig P Hensley1, Abel N Kho1, Andrew Kritselis2
1Northwestern University Feinberg School of Medicine, Chicago, Illinois.
ACR open rheumatology
|September 11, 2025
概括
在全关节整形术 (THA) 后的跌倒很常见. 术前的因素,如先前的跌倒和抑郁症,在THA后的一年内显著增加了跌倒风险,为预防策略提供了信息.
科学领域:
- 整形外科 整形外科 整形外科
- 老年病的医生 老年病的医生
- 公共卫生 公共卫生
背景情况:
- 跌倒是关节整形术 (THA) 后的重大并发症,影响患者的康复和增加医疗保健成本.
- 确定手术前的风险因素对于制定有针对性的干预措施来缓解老年人THA后跌倒风险至关重要.
研究的目的:
- 在65岁及以上的患者中,确定在关节整形术 (THA) 后一年内发生的跌倒相关的术前因素.
主要方法:
- 一项回顾性队列研究,使用来自大型医院系统的电子健康记录.
- 包括在2012年3月至2022年3月期间接受THA治疗的65岁以上的成年人.
- 后勤回归分析确定了THA后一年内跌倒的术前预测因素.
主要成果:
- 在4,501名患者中,有15.2%的患者在THA后一年内至少有一次跌倒.
- 手术前跌倒 (OR=2.67) 和抑郁 (OR=1.95) 是最强的预测因素.
- 其他风险因素包括神经疾病,失眠,THA修订,膝盖疼痛,腰部疾病和低BMI (<20 kg/m2).
结论:
- 多个手术前的因素独立地预测THA.之后的一年内下降.
- 调查结果强调了应对可修改的风险因素和实施量身定制的防摔计划的重要性.
- 个性化排放规划和管理策略可以减少THA后的跌倒风险.
相关概念视频
Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
Pharmacodynamics in Geriatric Patients: Effects of Age
190
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
190
Peripheral Artery Disease V: Postoperative Nursing Management
379
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
379
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
234
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
234
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
238
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
238
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
198
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
198


